Compare IVR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVR | CRMD |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 708.6M | 618.2M |
| IPO Year | N/A | 2009 |
| Metric | IVR | CRMD |
|---|---|---|
| Price | $8.33 | $7.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $8.25 | ★ $14.83 |
| AVG Volume (30 Days) | ★ 2.0M | 924.9K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 17.80% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 2.04 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $150.63 | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.63 | ★ $3.73 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $7.10 | $6.13 |
| 52 Week High | $9.50 | $17.43 |
| Indicator | IVR | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 61.19 |
| Support Level | $8.26 | $7.05 |
| Resistance Level | $8.44 | $8.53 |
| Average True Range (ATR) | 0.16 | 0.28 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 65.56 | 82.26 |
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.